Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Company Overview

Universe Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China.

Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products. Its offerings are derived in part from traditional Chinese medicine formulations and are intended to address a range of consumer health needs. The company also provides related product distribution and marketing services.

Founded in 1998, Universe Pharmaceuticals is headquartered in Xi’an, Shaanxi Province, China. Its operations and primary market are concentrated in mainland China. The company completed its initial public offering on the Nasdaq Capital Market in 2021.

Key Stats

• Today's Range: $3.96 to $4.21
• 50-Day Range: $3.88 to $7.09
• 52-Week Range: $2.00 to $17.96
• Volume: 12,062 shs
• Average Volume: 62,193 shs
• Market Capitalization: $20.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Universe Pharmaceuticals Stock Analysis - MarketRank™

Universe Pharmaceuticals scored higher than 21% of companies evaluated by MarketBeat, and ranked 800th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Universe Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Universe Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Universe Pharmaceuticals has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.05% of the float of Universe Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Universe Pharmaceuticals has a short interest ratio ("days to cover") of 1.08, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Universe Pharmaceuticals has recently decreased by 42.16%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Universe Pharmaceuticals does not currently pay a dividend.

Dividend Growth

Universe Pharmaceuticals does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.61

News Sentiment

Universe Pharmaceuticals has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Universe Pharmaceuticals this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for UPC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.

Percentage Held by Insiders

57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.18% of the stock of Universe Pharmaceuticals is held by institutions.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/10/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:UPC
• Previous Symbol: NYSE:UPC
• CIK: 1809616
• Web: www.universe-pharmacy.com
• Phone: 86-0796-8403309
• Fax: N/A
• Employees: 216
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 4.05
• Quick Ratio: 3.90

Sales & Book Value

• Annual Sales: $17.86 million
• Price / Sales: 1.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $99.64 per share
• Price / Book: 0.04

Miscellaneous

• Outstanding Shares: 5,020,000
• Free Float: 2,141,000
• Market Cap: $20.83 million
• Optionable: N/A
• Beta: 1.68